<DOC>
	<DOCNO>NCT00602147</DOCNO>
	<brief_summary>RATIONALE : Studying blood mouthwash sample laboratory patient receive melphalan cancer may help doctor learn change occur DNA , identify biomarkers related cancer , help predict patient respond treatment . PURPOSE : This clinical trial study common genetic mutation relate mucositis patient multiple myeloma receive high-dose melphalan .</brief_summary>
	<brief_title>Studying Common Genetic Mutations Related Mucositis Patients With Multiple Myeloma Receiving High-Dose Melphalan</brief_title>
	<detailed_description>OBJECTIVES : - To determine whether single nucleotide polymorphism ( SNPs ) gene encode melphalan transporter associate development and/or severity mucositis patient multiple myeloma receive high-dose melphalan . - To determine whether SNPs gene influence melphalan metabolism associate development and/or severity mucositis patient . OUTLINE : This multicenter study . Blood mouthwash sample collect DNA isolate specimen analyze single nucleotide polymorphism ( SNPs ) LAT1 candidate gene . Public database ( i.e. , dbSNP HapMap ) review select representative SNPs genotype analysis .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis multiple myeloma Receiving treatment highdose melphalan autologous stem cell transplantation facility : Vanderbilt University Medical Center Nashville Veteran 's Administration Medical Center ( VAMC ) Seattle VAMC San Antonio VAMC PATIENT CHARACTERISTICS : Not pregnant PRIOR CONCURRENT THERAPY : See Disease Characteristics No palifermin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>mucositis</keyword>
	<keyword>stage I multiple myeloma</keyword>
	<keyword>stage II multiple myeloma</keyword>
	<keyword>stage III multiple myeloma</keyword>
	<keyword>refractory multiple myeloma</keyword>
</DOC>